| 23.07 0.86 (3.87%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 26.99 |
1-year : | 31.52 |
| Resists | First : | 23.11 |
Second : | 26.99 |
| Pivot price | 21.6 |
|||
| Supports | First : | 20.75 |
Second : | 19.29 |
| MAs | MA(5) : | 22.37 |
MA(20) : | 21.36 |
| MA(100) : | 21.38 |
MA(250) : | 17.89 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 83.3 |
D(3) : | 82.8 |
| RSI | RSI(14): 68.2 |
|||
| 52-week | High : | 24.98 | Low : | 11.84 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ MD ] has closed above the upper band by 3.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 16.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 23.14 - 23.22 | 23.22 - 23.29 |
| Low: | 21.86 - 21.97 | 21.97 - 22.05 |
| Close: | 22.91 - 23.07 | 23.07 - 23.21 |
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Fri, 17 Apr 2026
Truist Lifts PT on Pediatrix Medical Group (MD) to $23 From $21 – Here’s Why - Yahoo! Finance Canada
Wed, 15 Apr 2026
Here's why Pediatrix Medical Group (MD) is a strong growth stock - MSN
Wed, 15 Apr 2026
A Look Back at Healthcare Providers & Services Stocks’ Q4 Earnings: Pediatrix Medical Group (NYSE:MD) Vs The Rest Of The Pack - Yahoo Finance
Wed, 15 Apr 2026
Phocas Financial Corp. Acquires 103,328 Shares of Pediatrix Medical Group, Inc. $MD - MarketBeat
Tue, 14 Apr 2026
Is Pediatrix Medical Group Inc (MD) Overvalued After 3.7% Rally? - GuruFocus
Sun, 12 Apr 2026
UBS Maintains Pediatrix Medical Group (MD) Neutral Recommendation - MSN
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 83 (M) |
| Shares Float | 80 (M) |
| Held by Insiders | 2.2 (%) |
| Held by Institutions | 104.2 (%) |
| Shares Short | 3,040 (K) |
| Shares Short P.Month | 2,960 (K) |
| EPS | 1.94 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.68 |
| Profit Margin | 8.6 % |
| Operating Margin | 11 % |
| Return on Assets (ttm) | 6.5 % |
| Return on Equity (ttm) | 20.2 % |
| Qtrly Rev. Growth | -1.8 % |
| Gross Profit (p.s.) | 5.94 |
| Sales Per Share | 22.99 |
| EBITDA (p.s.) | 3.04 |
| Qtrly Earnings Growth | 11.3 % |
| Operating Cash Flow | 271 (M) |
| Levered Free Cash Flow | 190 (M) |
| PE Ratio | 11.89 |
| PEG Ratio | 0 |
| Price to Book value | 2.16 |
| Price to Sales | 1 |
| Price to Cash Flow | 7.06 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|